microdosing with tirzepatide Program Tirzepatide microdose chart: your complete

Amy Marsteller breaks down the fascinating science behind GLP-1 medicaitons, how they work, who may qualify, and what patients should consider before starting treatment

Researchers say the next step is determining whether these newer GLP-1 drugs can also reduce cravings unrelated to food

& Ferguson, S

Both amlodipine besylate and sitagliptin phosphate had not been issued new CEPs or revisions in Q1 2025

For instance, New Zealand guidelines recommend offering GLP1RAs to all patients with HbA1c levels above target, especially when GLP1RA use would provide additional reductions in cardiovascular risk and/or permit reduction or cessation of other therapies that contribute to weight gain or hypoglycemia